107 related articles for article (PubMed ID: 25432133)
1. The human epididymis protein 4 acts as a prognostic factor and promotes progression of gastric cancer.
Guo YD; Wang JH; Lu H; Li XN; Song WW; Zhang XD; Zhang WM
Tumour Biol; 2015 Apr; 36(4):2457-64. PubMed ID: 25432133
[TBL] [Abstract][Full Text] [Related]
2. KITENIN is associated with tumor progression in human gastric cancer.
Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis.
Tsai CY; Wang CS; Tsai MM; Chi HC; Cheng WL; Tseng YH; Chen CY; Lin CD; Wu JI; Wang LH; Lin KH
Clin Cancer Res; 2014 May; 20(9):2276-88. PubMed ID: 24602839
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer.
Wang YY; Li L; Ye ZY; Zhao ZS; Yan ZL
World J Surg Oncol; 2015 Aug; 13():259. PubMed ID: 26311318
[TBL] [Abstract][Full Text] [Related]
5. Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker.
Tseng CW; Yang JC; Chen CN; Huang HC; Chuang KN; Lin CC; Lai HS; Lee PH; Chang KJ; Juan HF
Proteomics; 2011 Jun; 11(12):2423-39. PubMed ID: 21598387
[TBL] [Abstract][Full Text] [Related]
6. JMJD2A predicts prognosis and regulates cell growth in human gastric cancer.
Hu CE; Liu YC; Zhang HD; Huang GJ
Biochem Biophys Res Commun; 2014 Jun; 449(1):1-7. PubMed ID: 24802408
[TBL] [Abstract][Full Text] [Related]
7. PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion.
Yang L; Zhu J; Huang H; Yang Q; Cai J; Wang Q; Zhu J; Shao M; Xiao J; Cao J; Gu X; Zhang S; Wang Y
PLoS One; 2015; 10(10):e0140451. PubMed ID: 26488471
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer.
Zhu L; Zhuang H; Wang H; Tan M; Schwab CL; Deng L; Gao J; Hao Y; Li X; Gao S; Liu J; Lin B
Oncotarget; 2016 Jan; 7(1):729-44. PubMed ID: 26575020
[TBL] [Abstract][Full Text] [Related]
9. Human epididymis protein 4, a novel potential biomarker for diagnostic and prognosis monitoring of lung cancer.
Zhang T; Chu L; Tan W; Ye C; Dong H
Clin Respir J; 2024 May; 18(5):e13774. PubMed ID: 38742362
[TBL] [Abstract][Full Text] [Related]
10. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
Tang H; Deng M; Tang Y; Xie X; Guo J; Kong Y; Ye F; Su Q; Xie X
Clin Cancer Res; 2013 Oct; 19(20):5602-12. PubMed ID: 23995857
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer.
Lee BL; Lee HS; Jung J; Cho SJ; Chung HY; Kim WH; Jin YW; Kim CS; Nam SY
Clin Cancer Res; 2005 Apr; 11(7):2518-25. PubMed ID: 15814628
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of PI3K, Akt and survivin expression in gastric cancer.
Gu Y; Jin S; Wang F; Hua Y; Yang L; Shu Y; Zhang Z; Guo R
Biomed Pharmacother; 2014 May; 68(4):471-5. PubMed ID: 24726064
[TBL] [Abstract][Full Text] [Related]
13. Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
Wang X; Yu Z; Zhou Q; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
Oncotarget; 2016 Feb; 7(6):7066-79. PubMed ID: 26771235
[TBL] [Abstract][Full Text] [Related]
14. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic significance of Livin in gastric cancer.
Chung CY; Park YL; Kim N; Park HC; Park HB; Myung DS; Kim JS; Cho SB; Lee WS; Joo YE
Oncol Rep; 2013 Nov; 30(5):2520-8. PubMed ID: 24008725
[TBL] [Abstract][Full Text] [Related]
16. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
[TBL] [Abstract][Full Text] [Related]
17. VEZT as a novel independent prognostic factor in gastric cancer.
Li YS; Chen YZ; Guo XB; Liu X; Li LP
Cancer Biomark; 2015; 15(4):375-80. PubMed ID: 25792470
[TBL] [Abstract][Full Text] [Related]
18. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
19. Intelectin 1 suppresses tumor progression and is associated with improved survival in gastric cancer.
Li D; Zhao X; Xiao Y; Mei H; Pu J; Xiang X; Jiao W; Song H; Qu H; Huang K; Zheng L; Tong Q
Oncotarget; 2015 Jun; 6(18):16168-82. PubMed ID: 25965823
[TBL] [Abstract][Full Text] [Related]
20. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
